Robot model
Lokomat
Robot-assisted treadmill training system for lower-limb neurological rehabilitation.
- Manufacturer
- DIH Holding
- Form factor
- exoskeleton
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 3
Overview
Robot-assisted treadmill training system for lower-limb neurological rehabilitation. The most widely deployed rehabilitation exoskeleton globally with 1,219 systems installed in 650+ facilities. Manufactured by Hocoma (a DIH subsidiary) in Switzerland. Used for stroke, spinal cord injury, and neurological disorder therapy.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Sources on file
- View all sources →
Key facts
Form factor
Components
Conditions treated
Specs
Components
Conditions treated
Data & sources
Company filings
1
Web sources
1
2 sources backing this record.View all →
Pricing
No verified price is on record for Lokomat. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Deployments (3)
- Lokomat at Zürich, Switzerlandoperational
Operated by DIH Medical
Lokomat robotic gait rehabilitation system deployed in clinical rehabilitation centers worldwide.
- Lokomat at Global (multiple sites)operational
1,219 Lokomat systems installed in 650+ rehabilitation facilities worldwide.
- Lokomat at Globaloperational
Operated by Hocoma
Hocoma Lokomat robotic gait trainer deployed at rehabilitation hospitals globally.
Lokomat on the deployment map
View the global mapWhere Lokomat is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 27, 2026
Added to the verified registry
- Verified media addedVerifiedJun 11, 2026
Hocoma - Lokomat
- Deployment verifiedVerifiedJun 1, 2024
at Global
- Deployment verifiedVerifiedJan 1, 2015
at Zürich, Switzerland
- Deployment verifiedVerifiedJan 1, 2014
at Global (multiple sites)
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Incidents affecting Lokomat (1)
- FDA Class 2 recall of Hocoma Lokomat System due to software sensitivity bug2009-05-27 · Recall
Includes incidents linked directly to this model or to deployments of it. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Sources (2)
Mentioned on (1)
Registry pages whose text names Lokomat.
Companies (1)
Common questions
What is Lokomat?
How much does Lokomat cost?
Is Lokomat actually deployed in the real world?
Who makes Lokomat?
Where is Lokomat deployed?
Can you buy Lokomat?
What are alternatives to Lokomat?
How does Lokomat compare to Ant-H1 Pro?
Is Lokomat a top exoskeleton?
What is Lokomat's maturity stage?
Is Lokomat safe?
What is the DIH Lokomat rehabilitation robot?
Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-10-10
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-10-10
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: exoskeleton
Sources by quality tier
- 1
- unclassified
- Unclassified source
- 1
- primary-sec-filing
- SEC filing
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Lokomat.Recent coverage
Lokomat in third-party press
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning Lokomat from third-party publications. Automatically surfaced; not part of the verified registry record.
DIH Holding US (DHAI) Stock Price, News & Analysis
DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors
DIH Appoints Barrett Mooney, Ph.D to DIH Holding US Board of Directors
DIH Holding US, Inc. Appoints Scott R. Burell to Board of Directors
Augmenting rehabilitation robotics with spinal cord neuromodulation: A proof of concept
DIH Appoints Dietmar Dold as Chief Operating Officer
Updated Investor Deck dated July 15, 2024 - SEC.gov
DIH Appoints Anthony Pratt as VP of Commercial for the Americas
DIH Announces $1.5 million Private Placement Financing from OrbiMed
Aurora Technology Acquisition Overcomes Nasdaq Challenge, Completes DIH Deal
DIH Holding US Closes Business Combination with Aurora Technology Acquisition Corp.
Aurora Technology-DIH Deal in Jeopardy as SPAC Faces Nasdaq Suspension
Machine-readable surfaces
- Markdown mirror: /models/dih-holding-lokomat.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/e9a47bac-15ff-4dcc-b646-cab3a9689b2c
- Revision history: /models/dih-holding-lokomat/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
Lokomat draws attention at the 72nd percentile but verifies reality at the 80th percentile among exoskeletons. Hype Gap -7.4, 24th widest among exoskeletons.
6-month trend
Analysis
Thin deployment record; scale validation still in progress.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Nov 20, 2026